Aleafia Health Inc. reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was CAD 14.75 million compared to CAD 11.98 million a year ago. Revenue was CAD 10.79 million compared to CAD 8.76 million a year ago. Net loss was CAD 25.13 million compared to CAD 71.51 million a year ago. Basic loss per share from continuing operations was CAD 0.06 compared to CAD 0.22 a year ago.
For the nine months, sales was CAD 45.66 million compared to CAD 36.01 million a year ago. Revenue was CAD 33.45 million compared to CAD 29.46 million a year ago. Net loss was CAD 22.56 million compared to CAD 146.61 million a year ago. Basic loss per share from continuing operations was CAD 0.06 compared to CAD 0.44 a year ago.